|The viral paradigm in type 1 diabetes: Who are the main suspects?|
T Rodriguez-Calvo, S Sabouri, F Anquetil, MG von Herrath
Autoimmunity reviews 15 (10), 964-969, 2016
|Heterogeneity and lobularity of pancreatic pathology in type 1 diabetes during the prediabetic phase|
T Rodriguez-Calvo, JS Suwandi, N Amirian, J Zapardiel-Gonzalo, ...
Journal of Histochemistry & Cytochemistry 63 (8), 626-636, 2015
|The AID dilemma: infection, or cancer?|
T Honjo, M Kobayashi, N Begum, A Kotani, S Sabouri, H Nagaoka
Advances in cancer research 113, 1-44, 2012
|Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation|
M Kobayashi, Z Sabouri, S Sabouri, Y Kitawaki, Y Pommier, T Abe, ...
Proceedings of the National Academy of Sciences 108 (48), 19305-19310, 2011
|Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population|
S Sabouri, M Ghayour Mobarhan, M Moohebati, M Hassani, J Kassaeian, ...
The scientific world journal 11, 93-101, 2011
|C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion|
S Sabouri, M Kobayashi, NA Begum, J Xu, K Hirota, T Honjo
Proceedings of the National Academy of Sciences 111 (6), 2253-2258, 2014
|Association between angiotensin II type 1 receptor gene polymorphism and metabolic syndrome in a young female Iranian population|
J Alavi-Shahri, J Behravan, M Hassany, F Tatari, J Kasaian, R Ganjali, ...
Archives of medical research 41 (5), 343-349, 2010
|Alpha cells, the main source of IL-1β in human pancreas|
F Anquetil, S Sabouri, C Thivolet, T Rodriguez-Calvo, ...
Journal of autoimmunity 81, 68-73, 2017
|Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes|
S Sabouri, MA Benkahla, WB Kiosses, T Rodriguez-Calvo, ...
Journal of Autoimmunity 107, 102378, 2020
|OAS1 is not associated with MHC class I hyperexpression in the islets of donors with T1D regardless of disease duration.|
S Sabouri, Z Mikulski, MG von Herrath
Clinical immunology (Orlando, Fla.) 191, 34, 2018